个人简历

    陈大义，教授，硕士生导师。毕业于原华西医科大学公共卫生学院，从事营养与食品卫生相关教学和科研30余年，承担部省级以上课题20多项，出版教材、论著6部，发表文章30余篇，曾在日本国立卫生试验所做访问学者，现任中华预防医学会卫生检验分会委员、卫生管理分会委员，四川省预防医学会常委、四川省营养学会常委、四川省食品科学技术学会常委，担任四川省食品安全委员会委员、四川省农产品安全委员会委员。

 代表性成果

[1] Xiaoqi Pan, Lan Dong, Lian Yang, Dayi Chen, Cheng Peng*. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus Res. 2020, 286: 198057.

[2] Li-Juan Wu, Xiao-Yan He, Jing-Tao Liang, Jie Liang, Fei Wang, Da-Yi .ChenIntragastric administration of dahuang zhechong pill modulates TGF-b1/ smad signaling pathway in murine model of experimental silicosis.J.Journal of King Saud University-Science. 2020, 32(7): 3223-3229.

[3] Li-Juan Wu, Xiao-Yan He, Wen-Xiang Wang, Jie Liang, Yu-Die Zhang, Jing-Tao Liang, and Da-Yi Chen. Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF-β1/Smad Pathway In Vitro. Evid Based Complement Alternat Med. 2021: 6662261.

[4] Jie Zhou, Fu Peng, Xiaoyu Cao, Xiaofang Xie, Dayi Chen, Lian Yang, Chaolong Rao, Cheng Peng and Xiaoqi Pan. Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica–Induced Cardiotoxicity. Frontiers in Pharmacology. 2021, 12: 578796.